Skip to content

Education Impact on Rehabilitation of Hospitalized Patients With Pneumonia and COVID-19

The Impact of Education on the Rehabilitation of Patients Hospitalized Due to Pneumonia With Confirmed COVID-19

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06522724
Enrollment
100
Registered
2024-07-26
Start date
2024-07-26
Completion date
2024-10-26
Last updated
2024-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia Due to COVID-19

Keywords

pulmonary rehabilitation, COVID-19, pneumonia, patients' education

Brief summary

The planned research will enable the assessment of rehabilitation's effects using two pulmonary rehabilitation models: conventional and supplemented with an education program for patients hospitalized due to pneumonia with confirmed COVID-19.

Detailed description

The planned group size is 60 patients diagnosed with pneumonia and confirmed COVID-19. The given population was calculated based on the sampling calculator, considering the following parameters: fraction size, confidence level, and maximum error. Eligible patients will be randomly divided into two groups: a study group (30 patients) undergoing pulmonary rehabilitation supplemented with an education program, and a control group (30 patients) undergoing conventional pulmonary rehabilitation. Patients of both groups will be included in a 14-day rehabilitation program (Monday to Saturday). Treatments and therapies will be continued for a maximum of three hours daily. The program will be applied individually to each patient and include in-bed assisted exercises, airway clearance techniques, effective cough exercises, pursed-lips breathing, exercises to strengthen the diaphragm and intercostal muscles and cardiopulmonary exercises. Patients from the study group will additionally undergo daily education using an original brochure containing information about self management during the treatment process, the benefits of appropriately adapted physical activity, practical tips on airway clearance techniques or physical exercise. The test will be performed two times: before the start of rehabilitation and after completing the rehabilitation program. The patients' condition and the rehabilitation effects will be assessed using the following measures: * Vital capacity (Voldyne 5000) * Oxygen saturation (pulse oximeter) * Acid-base balance (gasometry) * Fatigue (modified Borg scale) * Physical performance (Sit-to-Stand Test) * Dyspnea assessment (MRC dyspnea scale) * Anxiety and depression (HADS scale) * Activities of daily living (Barthel scale)

Interventions

OTHEREducation program

Patients in a study group will participate in daily education program using an original brochure containing information about self-management during the treatment process, the benefits of appropriately adapted physical activity, practical tips on airway clearance techniques or physical exercise.

OTHERPulmonary rehabilitation

The patients will participate in a 14-day rehabilitation program (Monday to Saturday). Treatments and therapies will be continued for a maximum of three hours daily. The program will be applied individually to each patient and include in-bed assisted exercises, airway clearance techniques, effective cough exercises, pursed-lips breathing, exercises to strengthen the diaphragm and intercostal muscles and cardiopulmonary exercises.

Sponsors

University of Rzeszow
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

random selection to two groups (study group and control group)

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Hospitalization due to pneumonia due to COVID-19 * Positive SARS-COV-2 PCR test * Independence in in-bed sitting position with lower extremities placed on the floor * Age 40 y.o. to 70 y.o. * No additional respiratory support (e.a. cardiopulmonary bypass machine, ventilator) * Informed, voluntary consent to participate in research.

Exclusion criteria

* Hospitalization due to pneumonia with negative SARS-COV-2 PCR test * Unstable medical condition hindering performing the examination * Age under 40 y.o. and over 70 y.o. * Cognitive deficits impairing the ability to understand and execute commands * Concomitant oncological, neurological, orthopedic, and psychiatric diseases may affect the examined persons' circulatory and respiratory functions, functional efficiency, quality of life, and emotional state. * Failure to complete a 14-day rehabilitation program * Lack of informed, voluntary consent to participate in research

Design outcomes

Primary

MeasureTime frameDescription
Vital capacity (Voldyne 5000)First examination- before the start of the 14-day rehabilitation programMeasurements will be performed with certified motivational spirometer, Voldyne 5000. Patient, in a sitting position, will inhale as much air as possible starting from residual volume (RV) level and approach to vital capacity (VC) level. The result will be read from the scale placed on the wall of the device.
Oxygen saturationFirst examination- before the start of the 14-day rehabilitation programMeasurements will be performed with pulse oximeter and the parameter analyzed will be SpO2 (oxygen saturation by pulse oximetry; percentage of oxygen in patients' blood).
Acid-base balanceFirst examination- before the start of the 14-day rehabilitation programThe gasometry results will be taken from patients' medical documentation. The parameters analyzed will be oxygen pressure (pO2) and carbon dioxide pressure (pCO2).

Secondary

MeasureTime frameDescription
Anxiety and depression assessment using HADS scaleFirst examination- before the start of the 14-day rehabilitation programThe scale consists of 16 statements to which the respondent refers on a four-point scale. Eight statements are used to measure anxiety and depression, each of which is rated on a scale of 0 to 3 points. The cut-off threshold is 7 points for depression and 7 points for anxiety. The intensity of depressed mood and anxiety will be analyzed.
Physical performance assessment by Sit-to-Stand Test (STS)First examination- before the start of the 14-day rehabilitation programThe test will be performed starting in sitting position in the chair with straight back, feet flat on the floor, and arms crossed over the chest or placed on the thighs. The patient will be instructed to stand up fully from the seated position and then sit back down as quickly and safely as possible during 30 seconds (number of standings in 30 seconds).
Activities of daily living assesment using Barthel scaleFirst examination- before the start of the 14-day rehabilitation programThe Barthel Scale will be used to measure patient's ability to perform activities of daily living (ADLs) independently, with scores ranging from 0 (completely dependent) to 100 (completely independent).
Fatigue assessment using modified Borg scaleFirst examination- before the start of the 14-day rehabilitation programFatigue will be examined during physical activity and the level of fatigue will be marked on a scale from 1 (no fatigue) to 10 (very very hard fatigue).
Dyspnea assessment with Medical Research Council dyspnea scaleFirst examination- before the start of the 14-day rehabilitation programPerceived breathlessness degree will be marked on a scale 0 (no breathlessness) to 4 (breathlessness at rest).

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026